Author Traffehn, Sarah

1 to 7 of 7 Items
  • 2014 Conference Abstract
    ​ ​DMF modulates pathogenic B cell function in chronic CNS autoimmune disease​
    Traffehn, S.; Metz, I.; Brueck, W. & Weber, M.​ (2014)
    Journal of Neuroimmunology275(1-2) ​12th International Congress of Neuroimmunology (ISNI)​, Mainz, GERMANY.
    Amsterdam​: Elsevier Science Bv. DOI: https://doi.org/10.1016/j.jneuroim.2014.08.609 
    Details  DOI  WoS 
  • 2014 Journal Article | 
    ​ ​Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity​
    Lehmann-Horn, K.; Kinzel, S.; Feldmann, L.; Radelfahr, F.; Hemmer, B.; Traffehn, S. & Bernard, C. C. A. et al.​ (2014) 
    Annals of Clinical and Translational Neurology1(7) pp. 490​-496​.​ DOI: https://doi.org/10.1002/acn3.71 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Conference Abstract
    ​ ​DMF treatment in a B-cell dependent EAE model​
    Traffehn, S.; Metz, I.; Brueck, W. & Weber, M. S.​ (2015)
    Multiple Sclerosis Journal21 ​31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)​, Barcelona, SPAIN.
    London​: Sage Publications Ltd.
    Details  WoS 
  • 2015 Conference Abstract
    ​ ​Increased nuclear Nrf2 expression after fumarate treatment for multiple sclerosis and psoriasis​
    Metz, I.; Traffehn, S.; Strassburger-Krogias, K.; Keyvani, K.; Bergmann, M.; Nolte, K.   & Weber, M. et al.​ (2015)
    Multiple Sclerosis Journal21 pp. 259​-260. ​31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)​, Barcelona, SPAIN.
    London​: Sage Publications Ltd.
    Details  WoS 
  • 2015 Journal Article | 
    ​ ​Cell type-specific Nrf2 expression in multiple sclerosis lesions​
    Licht-Mayer, S.; Wimmer, I.; Traffehn, S.; Metz, I.; Brueck, W.; Bauer, J. & Bradl, M. et al.​ (2015) 
    Acta Neuropathologica130(2) pp. 263​-277​.​ DOI: https://doi.org/10.1007/s00401-015-1452-x 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article | 
    ​ ​Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.​
    Metz, I.; Traffehn, S.; Straßburger-Krogias, K.; Keyvani, K.; Bergmann, M.; Nolte, K. & Weber, M. S. et al.​ (2015) 
    Neurology® neuroimmunology & neuroinflammation2(3) art. e99​.​ DOI: https://doi.org/10.1212/NXI.0000000000000099 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article | 
    ​ ​Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis​
    Traub, J.; Traffehn, S.; Ochs, J.; Häusser‐Kinzel, S.; Stephan, S.; Scannevin, R. & Brück, W. et al.​ (2019) 
    Brain Pathology29(5) pp. 640​-657​.​ DOI: https://doi.org/10.1111/bpa.12711 
    Details  DOI  PMID  PMC 

Researcher

Sort

issue date

ASC DESC

Items per Page